Talk:TNP-ATP

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Untitled[edit]

Added a source, more to follow--DRH91 (talk) 01:46, 22 October 2015 (UTC)[reply]

Article is no longer a dead end. More hyperlinks to follow.--DRH91 (talk) 01:47, 22 October 2015 (UTC)[reply]

Added category biophysics. Suggestions for other categories?--DRH91 (talk) 01:51, 22 October 2015 (UTC)[reply]

Added figure.--DRH91 (talk) 02:23, 22 October 2015 (UTC)[reply]

Wiki Education Foundation-supported course assignment[edit]

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): DRH91.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 04:00, 18 January 2022 (UTC)[reply]

Add Info about Use as P2X Receptor Antagonist[edit]

TNP-ATP has been used extensively as a P2X receptor antagonist, information about this common use of TNP-ATP. A great starting source for information on this is the introduction to the article "Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)"[1].--Emandems1 (talk) 03:33, 21 September 2018 (UTC)[reply]

References

  1. ^ Burgard, E.C.; Niforatos, W.; van Biesen, T.; Lynch, K.J.; Kage, K.L.; Touma, E.; Kowaluk, E.A.; Jarvis, M.F. (2000). "Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)". Molecular Pharmacology. 58 (6): 1502–1510. doi:10.1124/mol.58.6.1502. PMID 11093790. Retrieved 21 September 2018.